BUSINESS REGISTRATION NUMBER
BRN 75120520

Provectus Therapeutics Limited

胞羅萬測有限公司

Registry Verified: 2025-06-19
Jurisdiction: Hong Kong, China

Provectus Therapeutics Limited (胞羅萬測有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 3259581, and Business Registration Number (BRN) is 75120520. Incorporated on 2023-03-29, the entity has maintained continuous statutory operations for 3 years and 7 months, currently holding an active legal status of Live. The registered office is situated at 6/F, BUILDING 17W, 17 SCIENCE PARK WEST AVENUE, TAI PO, NEW TERRITORIES, HONG KONG. Regarding statutory filings, pursuant to Section 662 of the Companies Ordinance (Cap. 622), its annual return filing window falls between Mar 29 – May 10 (within 42 days after its incorporation anniversary), with the latest Annual Return (Form NAR1) officially filed on 2025-04-11; a total of 11 statutory filings (spanning 2023–2025, latest filed on 2025-06-19) are indexed in the registry, comprising 2 Annual Return(s) (NAR1), 2 officer/secretary change notice(s) (ND2A), 1 registered office change(s) (NR1), 1 corporate name change filing(s) (NNC2).

I. Corporate Profile & Statutory Registry Records

Official Chinese Name 胞羅萬測有限公司 Official English Name Provectus Therapeutics Limited
Name Evolution
(1 Former Name)
2023-03-29 Founding Incorp. Name
Provectus Therapeutics Limited
2025-06-19 Current Legal Name
胞羅萬測有限公司Provectus Therapeutics Limited
Company Reg No. (CRN) 3259581 Business Reg No. (BRN)
75120520
Incorporation Date 2023-03-29 Company Category Private company limited by shares
Current Legal Status Live Statutory Filing Cycle
2026-03-29
Registered Office Address
6/F, BUILDING 17W, 17 SCIENCE PARK WEST AVENUE, TAI PO, NEW TERRITORIES, HONG KONG
Significant Controllers (SCR) Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

II. Companies Registry Document Retrieval(Annual Return NAR1 & ND2A Filings)

#Filing DateDocument No.Document NamePagesTariffAction
12025-06-1970004721450
NNC2
Notice of Change of Company Name pursuant to Direction (English)
1HK$ 20
22025-06-1940024257010
DOC
Certificate of Change of Name
1HK$ 20
32025-04-1170004532518
NAR1
Annual Return (2025)Latest Shareholders & Directors
10HK$ 28
42024-10-0370004073387
ND2A
Notice of Change of Company Secretary and Director
3HK$ 20
52024-04-0270003665050
NAR1
Annual Return (2024)
12HK$ 28
62024-03-2770003649757
ND2B
Notice of Change of Company Secretary and Director (Particulars)
5HK$ 20
72024-03-2770003649725
NR1
Notice of Change of Address of Registered Office
1HK$ 20
82023-12-27SH001668197
BRN_REF
Reference Document for Business Registration Number as UBI
1HK$ 30
92023-03-2970003068363
NNC1
Incorporation Form (Company Limited by Shares)
10HK$ 28
102023-03-2970003068365
A&A
Articles of Association (A&A)
45HK$ 33

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.

IV. Corporate Statutory Dossier & Legal Status FAQ

Yes. Provectus Therapeutics Limited is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2023-03-29 (operating for 3 years). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: June 2025).

The statutory primary identifiers for Provectus Therapeutics Limited are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [75120520] (effective from 27 December 2023, this 8-digit number issued under Cap. 310 serves as the unified cross-departmental corporate identifier); 2. Company Registration Number (CRN): [3259581] (incorporation archive number issued under Cap. 622). Together, these dual keys uniquely lock the entity in international banking KYC and cross-border contracts.

Under the Companies Ordinance (Cap. 622) of Hong Kong, incorporated companies do not maintain a single 'legal representative' position; the Board of Directors (Section 643) exercises statutory management authority. Complete current and historical directorships (Form ND2A), registered member shareholdings (Form NAR1 / Section 627), and Ultimate Beneficial Ownership (UBO / SCR under Part 12 Division 2A) are verified through official statutory filing retrieval.

Yes. According to the official statutory records of the Hong Kong Companies Registry, Provectus Therapeutics Limited has officially recorded 1 legal name change(s): [Provectus Therapeutics Limited (effective 2023-03-29)]. Pursuant to Sections 107 and 109 of the Companies Ordinance (Cap. 622), each name change was passed by special resolution (Form NNC2) and took statutory effect upon issuance of a Certificate of Change of Name by the Registrar of Companies; under Section 109(4), changing the company name does not affect any rights, obligations, or legal proceedings of the company.

Yes. Statutory indexing confirms that Provectus Therapeutics Limited has accumulated 11 official filing dossier(s) archived in the Hong Kong Companies Registry (latest statutory filing indexed on 2025-06-19: Form NNC2 - Notice of Change of Company Name pursuant to Direction (English)). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days after each incorporation anniversary. Available barcoded dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and member shareholdings), Incorporation Form (Form NNC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A), each bearing authentic ICRIS electronic barcode verification.

The statutory registered office of Provectus Therapeutics Limited on official record is situated at: [6/F, BUILDING 17W, 17 SCIENCE PARK WEST AVENUE, TAI PO, NEW TERRITORIES, HONG KONG]. Official registry dossiers also record 1 statutory registered office address change filing(s) (Form NR1). Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.

V. Similar Trade Names & Industry Directory

Retrieve Filings